Does Our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics

Circulation: Cardiovascular Genetics

Volumn 8, Issue 1, 2015, Pages 187-191

  Griffin, Julian L ^a,b   Wang, Xinzhu ^a,b   Stanley, Elizabeth ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cardiovascular disease; Diabetes mellitus; Metabolomics; Microbiome; Obesity; Trimethylamine N oxide

Indexed keywords

AMINE; APOLIPOPROTEIN E; BETAINE; BETAINE HOMOCYSTEINE METHYLTRANSFERASE; CHOLESTEROL; CHOLINE; CHOLINE ACETYLTRANSFERASE; CHOLINE DEHYDROGENASE; CITRIC ACID; CREATINE KINASE; CREATININASE; DIMETHYLGLYCINE DEHYDROGENASE; ESTROGEN; FARNESOID X RECEPTOR; FUMARIC ACID; GLYCEROPHOSPHORYLCHOLINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALIC ACID; METHIONINE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE METHYLTRANSFERASE; PHOSPHORYLCHOLINE; PYRUVIC ACID; SARCOSINE DEHYDROGENASE; SPHINGOMYELIN; TRIMETHYLAMINE; TRIMETHYLAMINE OXIDE;

AMINO ACID METABOLISM; ATHEROSCLEROSIS; BIOAVAILABILITY; BIOSYNTHESIS; BRASSICA; CARBON METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIETARY INTAKE; EGG; EVIDENCE BASED MEDICINE; FISH; FOLATE METABOLISM; HUMAN; INSULIN RESISTANCE; INTESTINE FLORA; METABOLIC DISORDER; METABOLIC SYNDROME X; METABOLITE; METABOLOMICS; MICROBIAL METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RED MEAT; REVIEW; VEGETABLE; INTESTINE; METABOLISM; MICROBIOLOGY; MICROFLORA;

CARDIOVASCULAR DISEASES; HUMANS; INTESTINES; METABOLOMICS; MICROBIOTA;

EID: 84924586662     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.114.000219     Document Type: Review

References (64)

1. Paton NW, Khan SA, Hayes A, Moussouni F, Brass A, Eilbeck K, et al. Conceptual modelling of genomic information. Bioinformatics. 2000;16:548-557.
2. Raamsdonk LM, Teusink B, Broadhurst D, Zhang N, Hayes A, Walsh MC, et al. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat Biotechnol. 2001;19:45-50. doi: 10.1038/83496.
3. Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev. 2011;40:387-426. doi: 10.1039/b906712b.
4. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999;29:1181-1189. doi: 10.1080/004982599238047.
5. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov. 2002;1:153-161. doi: 10.1038/nrd728.
6. Phipps AN, Stewart J, Wright B, Wilson ID. Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica. 1998;28:527-537. doi: 10.1080/004982598239443.
7. Goodacre R. Metabolomics of a superorganism. J Nutr. 2007;137(suppl 1):259S-266S.
8. Nicholls AW, Mortishire-Smith RJ, Nicholson JK. NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem Res Toxicol. 2003;16:1395-1404. doi: 10.1021/tx0340293.
9. Wilson ID, Nicholson JK. The role of gut microbiota in drug response. Curr Pharm Des. 2009;15:1519-1523.
10. Nicholson JK, Holmes E, Lindon JC, Wilson ID. The challenges of modeling mammalian biocomplexity. Nat Biotechnol. 2004;22:1268-1274. doi: 10.1038/nbt1015.
11. Nicholson JK, Holmes E, Wilson ID. Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol. 2005;3:431-438. doi: 10.1038/nrmicro1152.
12. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al. Host-gut microbiota metabolic interactions. Science. 2012;336:1262-1267. doi: 10.1126/science.1223813.
13. Cani PD, Delzenne NM. Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care. 2007;10:729-734. doi: 10.1097/MCO.0b013e3282efdebb.
14. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57:1470-1481. doi: 10.2337/db07-1403.
15. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010;5:e9085. doi: 10.1371/journal.pone.0009085.
16. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155:1451-1463. doi: 10.1016/j.cell.2013.11.024.
17. Clayton TA. Metabolic differences underlying two distinct rat urinary phenotypes, a suggested role for gut microbial metabolism of phenylalanine and a possible connection to autism. FEBS Lett. 2012;586:956-961. doi: 10.1016/j.febslet.2012.01.049.
18. Yap IK, Angley M, Veselkov KA, Holmes E, Lindon JC, Nicholson JK. Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res. 2010;9:2996-3004. doi: 10.1021/pr901188e.
19. Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487:477-481. doi: 10.1038/nature11228.
20. Sinagra E, Tomasello G, Cappello F, Leone A, Cottone M, Bellavia M, et al. Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights. J Biol Regul Homeost Agents. 2013;27:919-933.
21. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A. 2009;106:3698-3703. doi: 10.1073/pnas.0812874106.
22. Stanley EG, Bailey NJ, Bollard ME, Haselden JN, Waterfield CJ, Holmes E, et al. Sexual dimorphism in urinary metabolite profiles of Han Wistar rats revealed by nuclear-magnetic-resonance-based metabonomics. Anal Biochem. 2005;343:195-202. doi: 10.1016/j.ab.2005.01.024.
23. Gavaghan McKee CL, Wilson ID, Nicholson JK. Metabolic phenotyping of nude and normal (Alpk:ApfCD, C57BL10J) mice. J Proteome Res. 2006;5:378-384. doi: 10.1021/pr050255h.
24. Bollard ME, Holmes E, Lindon JC, Mitchell SC, Branstetter D, Zhang W, et al. Investigations into biochemical changes due to diurnal variation and estrus cycle in female rats using high-resolution (1)H NMR spectroscopy of urine and pattern recognition. Anal Biochem. 2001;295:194-202. doi: 10.1006/abio.2001.5211.
25. Balaban RS, Knepper MA. Nitrogen-14 nuclear magnetic resonance spectroscopy of mammalian tissues. Am J Physiol. 1983;245(5 pt 1):C439-C444.
26. Bell JD, Lee JA, Lee HA, Sadler PJ, Wilkie DR, Woodham RH. Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethylamine-N-oxide. Biochim Biophys Acta. 1991;1096:101-107.
27. Hauet T, Baumert H, Gibelin H, Hameury F, Goujon JM, Carretier M, et al. Noninvasive monitoring of citrate, acetate, lactate, and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury. Cryobiology. 2000;41:280-291. doi: 10.1006/cryo.2000.2291.
28. Madsen K, Tinning AR, Marcussen N, Jensen BL. Postnatal development of the renal medulla; role of the renin-angiotensin system. Acta Physiol (Oxf). 2013;208:41-49. doi: 10.1111/apha.12088.
29. Lang DH, Yeung CK, Peter RM, Ibarra C, Gasser R, Itagaki K, et al. Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3. Biochem Pharmacol. 1998;56:1005-1012.
30. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57-63. doi: 10.1038/nature09922.
31. Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368:1575-1584. doi: 10.1056/NEJMoa1109400.
32. Loscalzo J. Gut microbiota, the genome, and diet in atherogenesis. N Engl J Med. 2013;368:1647-1649. doi: 10.1056/NEJMe1302154.
33. Rak K, Rader DJ. Cardiovascular disease: the diet-microbe morbid union. Nature. 2011;472:40-41. doi: 10.1038/472040a.
34. Zeisel SH. Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr. 2006;26:229-250. doi: 10.1146/annurev.nutr.26.061505.111156.
35. Cheng W-L, Holmes-McNary MQ, Mar M-H, Lien EL, Zeisel SH. Bioavailability of choline and choline esters from milk in rat pups. J Nutr Biochem. 1996;7:457-464.
36. Guba SC, Fink LM, Fonseca V. Hyperhomocysteinemia. An emerging and important risk factor for thromboembolic and cardiovascular disease. Am J Clin Pathol. 1996;106:709-722.
37. Lattard V, Lachuer J, Buronfosse T, Garnier F, Benoit E. Physiological factors affecting the expression of FMO1 and FMO3 in the rat liver and kidney. Biochem Pharmacol. 2002;63:1453-1464.
38. Ayesh R, Mitchell SC, Smith RL. Dysfunctional N-oxidation of trimethylamine and the influence of testosterone treatment in man. Pharmacogenetics. 1995;5:244-246.
39. Mitchell SC, Smith RL. Trimethylaminuria: the fish malodor syndrome. Drug Metab Dispos. 2001;29(4 pt 2):517-521.
40. Li M, Al-Sarraf A, Sinclair G, Frohlich J. Fish odour syndrome. CMAJ. 2011;183:929-931. doi: 10.1503/cmaj.100642.
41. Noga AA, Vance DE. A gender-specific role for phosphatidylethanolamine N-methyltransferase-derived phosphatidylcholine in the regulation of plasma high density and very low density lipoproteins in mice. J Biol Chem. 2003;278:21851-21859. doi: 10.1074/jbc.M301982200.
42. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-1031. doi: 10.1038/nature05414.
43. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010;328:228-231. doi: 10.1126/science.1179721.
44. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480-484. doi: 10.1038/nature07540.
45. Koren O, Spor A, Felin J, Fåk F, Stombaugh J, Tremaroli V, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4592-4598. doi: 10.1073/pnas.1011383107.
46. Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A. 2006;103:12511-12516. doi: 10.1073/pnas.0601056103.
47. Dumas ME, Wilder SP, Bihoreau MT, Barton RH, Fearnside JF, Argoud K, et al. Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models. Nat Genet. 2007;39:666-672. doi: 10.1038/ng2026.
48. Velagapudi VR, Hezaveh R, Reigstad CS, Gopalacharyulu P, Yetukuri L, Islam S, et al. The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res. 2010;51:1101-1112. doi: 10.1194/jlr.M002774.
49. Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall HU, Bamberg K, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013;17:225-235. doi: 10.1016/j.cmet.2013.01.003.
50. Li F, Jiang C, Krausz KW, Li Y, Albert I, Hao H, et al. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat Commun. 2013;4:2384. doi: 10.1038/ncomms3384.
51. Zuppi C, Messana I, Forni F, Rossi C, Pennacchietti L, Ferrari F, et al. 1H NMR spectra of normal urines: reference ranges of the major metabolites. Clin Chim Acta. 1997;265:85-97.
52. Svensson BG, Akesson B, Nilsson A, Paulsson K. Urinary excretion of methylamines in men with varying intake of fish from the Baltic Sea. J Toxicol Environ Health. 1994;41:411-420. doi: 10.1080/15287399409531853.
53. Zhang AQ, Mitchell SC, Smith RL. Dietary precursors of trimethylamine in man: a pilot study. Food Chem Toxicol. 1999;37:515-520.
54. Lenz EM, Bright J, Wilson ID, Hughes A, Morrisson J, Lindberg H, et al. Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects. J Pharm Biomed Anal. 2004;36:841-849. doi: 10.1016/j.jpba.2004.08.002.
55. Stella C, Beckwith-Hall B, Cloarec O, Holmes E, Lindon JC, Powell J, et al. Susceptibility of human metabolic phenotypes to dietary modulation. J Proteome Res. 2006;5:2780-2788. doi: 10.1021/pr060265y.
56. Cheng KK, Benson GM, Grimsditch DC, Reid DG, Connor SC, Griffin JL. Metabolomic study of the LDL receptor null mouse fed a high-fat diet reveals profound perturbations in choline metabolism that are shared with ApoE null mice. Physiol Genomics. 2010;41:224-231. doi: 10.1152/physiolgenomics.00188.2009.
57. Lv S, Fan R, Du Y, Hou M, Tang Z, Ling W, et al. Betaine supplementation attenuates atherosclerotic lesion in apolipoprotein E-deficient mice. Eur J Nutr. 2009;48:205-212. doi: 10.1007/s00394-009-0003-4.
58. Schwahn BC, Wang XL, Mikael LG, Wu Q, Cohn J, Jiang H, et al. Betaine supplementation improves the atherogenic risk factor profile in a transgenic mouse model of hyperhomocysteinemia. Atherosclerosis. 2007;195:e100-e107. doi: 10.1016/j.atherosclerosis.2007.06.030.
59. Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, et al. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest. 2001;107:675-683. doi: 10.1172/JCI10588.
60. Bennett BJ, de Aguiar Vallim TQ, Wang Z, Shih DM, Meng Y, Gregory J, et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013;17:49-60. doi: 10.1016/j.cmet.2012.12.011.
61. Stella C, Beckwith-Hall B, Cloarec O, Holmes E, Lindon JC, Powell J, et al. Susceptibility of human metabolic phenotypes to dietary modulation. J Proteome Res. 2006;5:2780-2788. doi: 10.1021/pr060265y.
62. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19:576-585. doi: 10.1038/nm.3145.
63. Ussher JR, Lopaschuk GD, Arduini A. Gut microbiota metabolism of Lcarnitine and cardiovascular risk. Atherosclerosis. 2013;231:456-461. doi: 10.1016/j.atherosclerosis.2013.10.013.
64. Ashrafian H, Li JV, Spagou K, Harling L, Masson P, Darzi A, et al. Bariatric surgery modulates circulating and cardiac metabolites. J Proteome Res. 2014;13:570-580. doi: 10.1021/pr400748f.